000143906 001__ 143906
000143906 005__ 20240229112612.0
000143906 0247_ $$2doi$$a10.1016/j.oraloncology.2019.05.006
000143906 0247_ $$2pmid$$apmid:31178212
000143906 0247_ $$2ISSN$$a1368-8375
000143906 0247_ $$2ISSN$$a1744-7895
000143906 0247_ $$2ISSN$$a1878-0601
000143906 0247_ $$2ISSN$$a1879-0593
000143906 0247_ $$2altmetric$$aaltmetric:60715029
000143906 037__ $$aDKFZ-2019-01464
000143906 041__ $$aeng
000143906 082__ $$a610
000143906 1001_ $$aDi Credico, Gioia$$b0
000143906 245__ $$aJoint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach.
000143906 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2019
000143906 3367_ $$2DRIVER$$aarticle
000143906 3367_ $$2DataCite$$aOutput Types/Journal article
000143906 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1560338915_923
000143906 3367_ $$2BibTeX$$aARTICLE
000143906 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143906 3367_ $$00$$2EndNote$$aJournal Article
000143906 520__ $$aThis study aimed at re-evaluating the strength and shape of the dose-response relationship between the combined (or joint) effect of intensity and duration of cigarette smoking and the risk of head and neck cancer (HNC). We explored this issue considering bivariate spline models, where smoking intensity and duration were treated as interacting continuous exposures.We pooled individual-level data from 33 case-control studies (18,260 HNC cases and 29,844 controls) participating in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. In bivariate regression spline models, exposures to cigarette smoking intensity and duration (compared with never smokers) were modeled as a linear piecewise function within a logistic regression also including potential confounders. We jointly estimated the optimal knot locations and regression parameters within the Bayesian framework.For oral-cavity/pharyngeal (OCP) cancers, an odds ratio (OR) >5 was reached after 30 years in current smokers of ∼20 or more cigarettes/day. Patterns of OCP cancer risk in current smokers differed across strata of alcohol intensity. For laryngeal cancer, ORs >20 were found for current smokers of ≥20 cigarettes/day for ≥30 years. In former smokers who quit ≥10 years ago, the ORs were approximately halved for OCP cancers, and ∼1/3 for laryngeal cancer, as compared to the same levels of intensity and duration in current smokers.Referring to bivariate spline models, this study better quantified the joint effect of intensity and duration of cigarette smoking on HNC risk, further stressing the need of smoking cessation policies.
000143906 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000143906 588__ $$aDataset connected to CrossRef, PubMed,
000143906 7001_ $$aEdefonti, Valeria$$b1
000143906 7001_ $$aPolesel, Jerry$$b2
000143906 7001_ $$aPauli, Francesco$$b3
000143906 7001_ $$aTorelli, Nicola$$b4
000143906 7001_ $$aSerraino, Diego$$b5
000143906 7001_ $$aNegri, Eva$$b6
000143906 7001_ $$aLuce, Daniele$$b7
000143906 7001_ $$aStucker, Isabelle$$b8
000143906 7001_ $$aMatsuo, Keitaro$$b9
000143906 7001_ $$aBrennan, Paul$$b10
000143906 7001_ $$aVilensky, Marta$$b11
000143906 7001_ $$aFernandez, Leticia$$b12
000143906 7001_ $$aCurado, Maria Paula$$b13
000143906 7001_ $$aMenezes, Ana$$b14
000143906 7001_ $$aDaudt, Alexander W$$b15
000143906 7001_ $$aKoifman, Rosalina$$b16
000143906 7001_ $$aWunsch-Filho, Victor$$b17
000143906 7001_ $$aHolcatova, Ivana$$b18
000143906 7001_ $$aAhrens, Wolfgang$$b19
000143906 7001_ $$aLagiou, Pagona$$b20
000143906 7001_ $$aSimonato, Lorenzo$$b21
000143906 7001_ $$aRichiardi, Lorenzo$$b22
000143906 7001_ $$aHealy, Claire$$b23
000143906 7001_ $$aKjaerheim, Kristina$$b24
000143906 7001_ $$aConway, David I$$b25
000143906 7001_ $$aMacfarlane, Tatiana V$$b26
000143906 7001_ $$aThomson, Peter$$b27
000143906 7001_ $$aAgudo, Antonio$$b28
000143906 7001_ $$aZnaor, Ariana$$b29
000143906 7001_ $$aBoaventura Rios, Leonardo F$$b30
000143906 7001_ $$aToporcov, Tatiana N$$b31
000143906 7001_ $$aFranceschi, Silvia$$b32
000143906 7001_ $$aHerrero, Rolando$$b33
000143906 7001_ $$aMuscat, Joshua$$b34
000143906 7001_ $$aOlshan, Andrew F$$b35
000143906 7001_ $$aZevallos, Jose P$$b36
000143906 7001_ $$aLa Vecchia, Carlo$$b37
000143906 7001_ $$aWinn, Deborah M$$b38
000143906 7001_ $$aSturgis, Erich M$$b39
000143906 7001_ $$aLi, Guojun$$b40
000143906 7001_ $$aFabianova, Eleonora$$b41
000143906 7001_ $$aLissowska, Jolanda$$b42
000143906 7001_ $$aMates, Dana$$b43
000143906 7001_ $$aRudnai, Peter$$b44
000143906 7001_ $$aShangina, Oxana$$b45
000143906 7001_ $$aSwiatkowska, Beata$$b46
000143906 7001_ $$aMoysich, Kirsten$$b47
000143906 7001_ $$aZhang, Zuo-Feng$$b48
000143906 7001_ $$aMorgenstern, Hal$$b49
000143906 7001_ $$aLevi, Fabio$$b50
000143906 7001_ $$aSmith, Elaine$$b51
000143906 7001_ $$aLazarus, Philip$$b52
000143906 7001_ $$aBosetti, Cristina$$b53
000143906 7001_ $$aGaravello, Werner$$b54
000143906 7001_ $$aKelsey, Karl$$b55
000143906 7001_ $$aMcClean, Michael$$b56
000143906 7001_ $$aRamroth, Heribert$$b57
000143906 7001_ $$aChen, Chu$$b58
000143906 7001_ $$aSchwartz, Stephen M$$b59
000143906 7001_ $$aVaughan, Thomas L$$b60
000143906 7001_ $$aZheng, Tongzhang$$b61
000143906 7001_ $$aMenvielle, Gwenn$$b62
000143906 7001_ $$aBoccia, Stefania$$b63
000143906 7001_ $$aCadoni, Gabriella$$b64
000143906 7001_ $$aHayes, Richard B$$b65
000143906 7001_ $$aPurdue, Mark$$b66
000143906 7001_ $$aGillison, Maura$$b67
000143906 7001_ $$aSchantz, Stimson$$b68
000143906 7001_ $$aYu, Guo-Pei$$b69
000143906 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b70$$udkfz
000143906 7001_ $$aD'Souza, Gypsyamber$$b71
000143906 7001_ $$aGross, Neil D$$b72
000143906 7001_ $$aChuang, Shu-Chun$$b73
000143906 7001_ $$aBoffetta, Paolo$$b74
000143906 7001_ $$aHashibe, Mia$$b75
000143906 7001_ $$aLee, Yuan-Chin Amy$$b76
000143906 7001_ $$aDal Maso, Luigino$$b77
000143906 773__ $$0PERI:(DE-600)2011971-9$$a10.1016/j.oraloncology.2019.05.006$$gVol. 94, p. 47 - 57$$p47 - 57$$tOral oncology$$v94$$x1368-8375$$y2019
000143906 909CO $$ooai:inrepo02.dkfz.de:143906$$pVDB
000143906 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b70$$kDKFZ
000143906 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000143906 9141_ $$y2019
000143906 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143906 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143906 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143906 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000143906 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000143906 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143906 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143906 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143906 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143906 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000143906 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143906 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000143906 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000143906 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000143906 980__ $$ajournal
000143906 980__ $$aVDB
000143906 980__ $$aI:(DE-He78)C070-20160331
000143906 980__ $$aI:(DE-He78)C120-20160331
000143906 980__ $$aI:(DE-He78)L101-20160331
000143906 980__ $$aUNRESTRICTED